| Bioactivity | Anticancer agent 170 (compound 3a) is a ketone derivative, and shows potency anti-cancer activity against A549, with the IC50 of 6.62 μM[1]. |
| Target | 6.62 μM(A549) |
| Name | Anticancer agent 170 |
| CAS | 24126-98-5 |
| Formula | C16H16O5 |
| Molar Mass | 288.30 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. John Alfon P. Francisco, et al. Inhibitory Effects of B-, C-, and E-Ring-Truncated Deguelin Derivatives Against A549, HCT116, and MCF-7 Cancer Cells. ACS Omega 2023, 8, 45, 43109–43117 |
Anticancer agent 170
CAS: 24126-98-5 F: C16H16O5 W: 288.30
Anticancer agent 170 (compound 3a) is a ketone derivative, and shows potency anti-cancer activity against A549, with the
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.